Skip to main content
. Author manuscript; available in PMC: 2014 Jun 3.
Published in final edited form as: Neuroscience. 2012 Oct 24;239:103–114. doi: 10.1016/j.neuroscience.2012.10.028

Figure 1.

Figure 1

Histogram of the number of lightly and intensely immunostained SNB motoneuron somata after immunolabeling for BDNF in castrated males with a testosterone (T) implant placed at the target muscle (black bars), castrated males with a T implant placed interscapularly (lightly shaded bars), castrated males with a blank implant placed at the target muscle (open bars), gonadally intact males with a hydroxyflutamide (HFL) implant placed interscapularly (hatched bars) and gonadally intact males with a hydroxyflutamide implant placed at the target muscle (darkly shaded bars). Bar heights represent means ± SEM. * Significantly different from castrated males with a T implant placed at the target muscle; † Significantly different from gonadally intact males with a hydroxyflutamide implant placed interscapularly. (Verhovshek et al., 2010a)